6/24/2022, 2:28 AM (Source: TeleTrader)
more TeleTrader news

Merck advances in talks to acquire Seagen - report

American pharmaceutical company Merck & Co., Inc. is making headway in its plans to perform a takeover of Seagen Inc., the Wall Street Journal reported on Friday.

According to WSJ sources, the companies' representatives are due to meet next week, to discuss what could be one of the biggest takeovers in 2022, given Seagen's $30 billion market value.

On Friday last week, WSJ first announced that Merck is in the process of negotiating a potential acquisition of Seagen, a Washington state biotech company focused on monoclonal antibody-based therapies for cancer treatment.

Baha Breaking News (BBN) / SP